Abstract
Background Omicron, the current SARS-CoV-2 variant of concern, is much more contagious than other previous variants. Whether strict lockdown could effectively curb the transmission of Omicron is largely unknown.
Methods In this retrospective study, we compared the strictness of government lockdown policies in Shanghai and some countries. Based on the daily Omicron case number from March 1st 2022 to April 30th 2022, the effective reproductive numbers in this Shanghai Omicron wave were calculated to confirm the impact of strict lockdown on Omicron transmission. Pearson correlation was conducted to illustrate the determining factor of strict lockdown outcomes in the 16 different districts of Shanghai.
Results After very strict citywide lockdown since April 1st, the average daily effective reproductive number reduced significantly, indicating that strict lockdown could slow down the spreading of Omicron. Omicron control is more challenging in districts with higher population mobility and lockdown is more likely to decrease the number of asymptomatic carrier than the symptomatic cases.
Conclusions The strict lockdown could curb the transmission of Omicron effectively, especially for the asymptomatic spread. And urban city with extensive personnel movement is suggested to adopt this lockdown strategy at early stage to maximally control the virus transmission.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the NSFC for Excellent Young Scientists of China (82122038), the National Key Research and Development Program of China (2017YFA0104600), NSFC Sino-German COVID International Collaboration Program (C-0025) to WZ.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the supplementary file.
